USD 10.57
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 215.45 Million | 204.34 Million | 193.97 Million | 224.53 Million | 143.61 Million | 112.55 Million |
Net Income | 114.01 Million | 116.68 Million | 85.38 Million | 170.38 Million | 95.14 Million | -12.41 Million |
Depreciation & Amortization | 55.35 Million | 53.74 Million | 50.91 Million | 41.09 Million | 36.44 Million | 30.1 Million |
Deferred income taxes | -132.55 Million | -40.52 Million | -27.61 Million | -64.23 Million | -7.03 Million | 36.1 Million |
Stock-based compensation | 21.84 Million | 27.63 Million | 27.59 Million | 47.3 Million | 36.83 Million | 1.8 Million |
Change in working capital | 34.24 Million | 25.29 Million | 39.11 Million | 10.04 Million | -62.72 Million | -24.71 Million |
Other non-cash items | 122.55 Million | 21.51 Million | 18.57 Million | 19.93 Million | 44.95 Million | 81.67 Million |
Investing Cash Flow | -29.56 Million | -10.82 Million | -38.92 Million | 110.24 Million | -20.87 Million | -11.17 Million |
Investments in PPE | -5.6 Million | -8.84 Million | -15.23 Million | -26.16 Million | -16.64 Million | -11.48 Million |
Acquisitions | -8.07 Million | -1.97 Million | -23.38 Million | 84.05 Million | - | - |
Investment purchases | -15.88 Million | - | -310 Thousand | -51 Thousand | -4.32 Million | - |
Sales/Maturities of investments | 18.15 Million | - | 15.23 Million | 26.16 Million | - | - |
Other Investing Activities | -18.15 Million | 1000.00 | -15.23 Million | 26.24 Million | 90 Thousand | 306 Thousand |
Financing Cash Flow | -272.98 Million | -609.8 Million | 301.1 Million | -95.76 Million | -136.1 Million | -55.94 Million |
Debt repayment | -100 Million | -470.37 Million | -77.93 Million | -62.83 Million | -696.37 Million | -5.01 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -161.9 Million | -300.08 Million | - | - | - | - |
Common Stock Issuance | - | - | - | - | 25 Thousand | - |
Other Financing Activities | -11.07 Million | 160.66 Million | 379.03 Million | -32.93 Million | 560.24 Million | -50.93 Million |
Accounts receivables | - | - | - | - | - | -4.22 Million |
Accounts payables | - | - | - | - | - | 3.03 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 34.24 Million | 25.29 Million | 39.11 Million | 10.04 Million | -62.72 Million | -23.3 Million |
Cash at beginning of period | 160.99 Million | 550.53 Million | 83.53 Million | 71.15 Million | 79.93 Million | 35.15 Million |
Cash at end of period | 72.82 Million | 160.99 Million | 550.53 Million | 83.53 Million | 71.15 Million | 79.93 Million |
Capital Expenditure | -5.6 Million | -8.84 Million | -15.23 Million | -26.16 Million | -16.64 Million | -11.48 Million |
Effect of forex changes on cash | -1.08 Million | 25.55 Million | 11.77 Million | -6.08 Million | 4.58 Million | 272 Thousand |
Net cash flow / Change in cash | -88.17 Million | -389.53 Million | 467 Million | 12.37 Million | -8.78 Million | 44.78 Million |
Free Cash Flow | 209.84 Million | 195.49 Million | 178.74 Million | 198.36 Million | 126.96 Million | 101.07 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 26.54 Million | 22.34 Million | 114.01 Million | 30.27 Million | 40.22 Million | 34.99 Million |
Depreciation & Amortization | 14.31 Million | 14.26 Million | 55.35 Million | 13.52 Million | 14.08 Million | 14.04 Million |
Deferred income taxes | - | - | -132.55 Million | -34.61 Million | -13.08 Million | -9.82 Million |
Stock-based compensation | 4.82 Million | 5.78 Million | 21.84 Million | 7.55 Million | -1.11 Million | 6.87 Million |
Change in working capital | 19.97 Million | 2.78 Million | 34.24 Million | 17.14 Million | 10.44 Million | 2.76 Million |
Other non-cash items | 33.72 Million | 32.91 Million | 122.55 Million | 27.44 Million | 3.9 Million | 3.7 Million |
Investing Cash Flow | -5.15 Million | -1.87 Million | -29.56 Million | -14.86 Million | -1.96 Million | -3.79 Million |
Investments in PPE | -1.1 Million | -1.87 Million | -5.6 Million | 1.24 Million | -1.71 Million | -1.76 Million |
Acquisitions | - | - | -8.07 Million | - | -250 Thousand | - |
Investment purchases | -4.04 Million | - | -15.88 Million | -13.84 Million | - | -2.03 Million |
Sales/Maturities of investments | - | - | 18.15 Million | - | - | - |
Other Investing Activities | -4.04 Million | - | -18.15 Million | -2.27 Million | - | -1.00 |
Financing Cash Flow | -50.59 Million | -79.05 Million | -272.98 Million | -52.6 Million | -44.85 Million | -55.3 Million |
Debt repayment | -20 Million | -10 Million | -100 Million | -5.91 Million | -2.27 Million | -1.52 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -26.61 Million | -67.69 Million | -161.9 Million | -46.69 Million | -37.77 Million | -51.85 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.66 Million | -5.77 Million | -11.07 Million | -5.91 Million | -7.08 Million | -3.44 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 19.97 Million | 2.78 Million | 34.24 Million | 17.14 Million | 10.44 Million | 2.76 Million |
Cash at beginning of period | 35.78 Million | 72.82 Million | 160.99 Million | 79.89 Million | 71.89 Million | 78.63 Million |
Cash at end of period | 45.89 Million | 35.78 Million | 72.82 Million | 72.82 Million | 79.89 Million | 71.89 Million |
Capital Expenditure | -1.1 Million | -1.87 Million | -5.6 Million | 1.24 Million | -1.71 Million | -1.76 Million |
Effect of forex changes on cash | -81 Thousand | 134 Thousand | -1.08 Million | -927 Thousand | 354 Thousand | -196 Thousand |
Net cash flow / Change in cash | 10.1 Million | -37.03 Million | -88.17 Million | -7.06 Million | 7.99 Million | -6.74 Million |
Free Cash Flow | 64.82 Million | 41.88 Million | 209.84 Million | 62.57 Million | 52.75 Million | 50.79 Million |
BKRKY
1359
BICEY
002278
5589
ULUSE